课题基金 / 基金详情

Investigation of Epigenetic Dysregulation in Lupus NK Cells

Investigation of Epigenetic Dysregulation in Lupus NK Cells
狼疮 NK 细胞表观遗传失调的研究
批准号:
10194280
负责人:
PAUL JOSEPH UTZ
金额:
$23.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-03 至 2023-02-28
关键词:
AffectAntigen-Antibody ComplexAtlasesBenchmarkingBiologicalBiological AssayBlood donorCell Adhesion MoleculesCell CompartmentationCell physiologyCell surfaceCell-Mediated CytolysisCellsCellular biologyChIP-seqCharacteristicsChromatinClinicalClinical ResearchComplexCytometryDNA MethylationDNA Sequence AlterationDataData SetDevelopmentDiseaseEpigenetic ProcessFluorescence-Activated Cell SortingFoundationsFrequenciesFunctional disorderFutureGeneticGenomicsGoalsGranzymeHeterogeneityHistone AcetylationHistone DeacetylaseHistonesImmuneImmune ToleranceImmune responseImmune systemIndividualInterferon Type IIInterventionInvestigationLightLinkLupusLysineMHC Class I GenesMeasuresMediatingMethodsModelingMolecularMonitorMonozygotic twinsNK Cell ActivationNatural Killer CellsOther GeneticsOutcomePathologicPatientsPatternPeripheral Blood Mononuclear CellPharmaceutical PreparationsPharmacologyPhenotypePlayPopulationProductionProteomicsReceptor CellRefractoryRegulationResolutionRoleSamplingSystemic Lupus ErythematosusTNF geneTechnologyTestingTherapeutic InterventionTransposaseVirus DiseasesVorinostatantibody-dependent cell cytotoxicitybaseclinically significantcytokinecytotoxicitydisease heterogeneitydisorder riskepigenetic markerepigenetic variationepigenomicsgenomic locushealthy volunteerhigh dimensionalityhigh rewardhigh riskhistone modificationhuman diseaseimmune functionindexinginnovationinsightnovelnovel therapeuticsperforinperipheral bloodreceptorsingle cell analysissingle cell technologysystemic inflammatory response

项目摘要

项目成果

PAUL JOSEPH UTZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY The overarching goal of this proposal is to systematically characterize an epigenetically distinct natural killer (NK) cell population with hypoacetylated histones. This NK cell subset is reduced in frequency in systemic lupus erythematosus (SLE) patients with increased disease activity. We will test the hypothesis that this NK cell subset, which we term “NKSLE cells”, has a distinct cell surface molecule profile, and is functionally different from other NK cells in cytolytic capacity and cytokine secretion upon activation. We will further examine if NK cell functions can be altered by experimental manipulation of histone acetylation. Our data will lay a strong foundation for future epigenomic studies on specific genes or genomic loci pivotal for lupus pathophysiology. The advent of single-cell technologies has greatly accelerated our understanding of immune system heterogeneity. Increasing evidence supports a compelling model in which pathologically important cells in SLE may represent only a small fraction of the highly complex immune system. This proposal builds upon this innovative concept, and will leverage cutting-edge technologies to interrogate the epigenetic and proteomic heterogeneity of NK cells, and their complex relationships. In Aim 1, we will employ highly multiplexed mass cytometry to monitor a broad array of functionally important NK cell markers, such as activating and inhibitory receptors, cell adhesion molecules, and those indicative of cytotoxicity activity, and histone acetylation abundance in individual NK cells. We will first benchmark NK cell heterogeneity in healthy blood donors, with a goal to identify cellular features associated with global histone acetylation level. Next, we will extend the analysis to SLE patients, whose NK cell compartments show reduced representation of cells with hypoacetylated histones. This study will reveal the phenotypic and functional characteristics of NKSLE cells. In Aim 2, we will investigate the functional differences between NK cells with differential histone acetylation content. Cytotoxicity and proinflammatory cytokine secretion are key immunological functions mediated by NK cells during a viral infection. Mass cytometry will be utilized to examine how differential histone acetylation abundance in individual NK cells is correlated with the degree of their immune response upon activation measured by degranulation markers, and cytokine production. Our analysis will first focus on NK cells isolated from healthy volunteers, and subsequently extend to those from lupus patients to better understand the clinical significance of NKSLE cell reduction in lupus. Lastly, as opposed to genetic mutations that are generally refractory to therapeutic interventions, epigenetic phenomena are largely reversible, making them attractive targets for developing new drugs. We will investigate the plasticity of NK cell functions by pharmacologically manipulating histone acetylation. Together, our proposal will provide new insights into the biological and pathological significance of histone acetylation in NK cell molecular and functional phenotypes. Our data will be valuable for future studies on lupus and other human diseases in which NK cells play important pathological roles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic Histone Landscape Profiles in HIV
  • 批准号:
    10535173
  • 项目类别:
  • 资助金额:
    $32.99万
  • 财政年份:
    2022
  • 负责人:
    PAUL JOSEPH UTZ
  • 依托单位:
Investigation of Epigenetic Dysregulation in Lupus NK Cells
  • 批准号:
    10363743
  • 项目类别:
  • 资助金额:
    $19.68万
  • 财政年份:
    2021
  • 负责人:
    PAUL JOSEPH UTZ
  • 依托单位:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
  • 批准号:
    10317652
  • 项目类别:
  • 资助金额:
    $15.8万
  • 财政年份:
    2020
  • 负责人:
    PAUL JOSEPH UTZ
  • 依托单位:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
  • 批准号:
    9975682
  • 项目类别:
  • 资助金额:
    $84.2万
  • 财政年份:
    2016
  • 负责人:
    PAUL JOSEPH UTZ
  • 依托单位:
海外基金